Evidence map›Paper›PMID 32006155›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2020

Association of estimated plasma volume status with hemodynamic and echocardiographic parameters.

Masatake Kobayashi, Olivier Huttin, Erwan Donal, Kevin Duarte, Arnaud Hubert, Hervé Le Breton, Elena Galli, Maxime Fournet, Philippe Mabo, Frederic Schnell and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Masatake KobayashiINSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Université de Lorraine, 4, rue du Morvan, 54500, Vandoeuvre-Les-Nancy, France.ORCID http://orcid.org/0000-0003-0008-2256
Olivier HuttinINSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Université de Lorraine, 4, rue du Morvan, 54500, Vandoeuvre-Les-Nancy, France.
Erwan DonalService de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Kevin DuarteINSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Université de Lorraine, 4, rue du Morvan, 54500, Vandoeuvre-Les-Nancy, France.
Arnaud HubertService de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Hervé Le BretonService de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Elena GalliService de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Maxime FournetService de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Philippe MaboService de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Frederic SchnellService de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Christophe LeclercqService de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Patrick RossignolINSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Université de Lorraine, 4, rue du Morvan, 54500, Vandoeuvre-Les-Nancy, France.
Nicolas GirerdINSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Université de Lorraine, 4, rue du Morvan, 54500, Vandoeuvre-Les-Nancy, France. n.girerd@chru-nancy.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEstimated plasma volume status (ePVS) has diagnostic and prognostic value in patients with heart failure (HF). However, it remains unclear which congestion markers (i.e., biological, imaging, and hemodynamic markers) are preferentially associated with ePVS. In addition, there is evidence of sex differences in both the hematopoietic process and myocardial structure/function. METHOD AND

resultsPatients with significant dyspnea (NYHA ≥ 2) underwent echocardiography and lung ultrasound within 4 h prior to cardiac catheterization. Patients were divided according to tertiles based on sex-specific ePVS thresholds calculated from hemoglobin and hematocrit measurements using Duarte's formula. Among the 78 included patients (median age 74.5 years; males 69.2%; HF 48.7%), median ePVS was 4.1 (percentile

conclusionePVS is associated with E/e' regardless of sex, while only associated with invasively measured left-ventricular end-diastolic pressure in females. These results suggest that ePVS is preferably associated with left-sided hemodynamic markers of congestion.

Indexed as

AgedAged, 80 and overEchocardiographyFemaleFollow-Up StudiesHeart FailureHemodynamicsHumansMaleMyocardial ContractionPlasma VolumePrognosisProspective StudiesStroke VolumeCongestionLeft-ventricular filling pressurePlasma volumeSex difference

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.